CTAs with a more restricted expressionpattern are more suitable targets for cancer immunotherapy.Among the four genes analyzed in thisstudy, ODF4 and RHOXF2 showed overexpressionin cancerous tissues compared with normaladjacent tissues. The gene discussed is RHOXF2; the disease is cancer.